These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7820779)

  • 21. Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.
    Tamagaki K; Yuan Q; Ohkawa H; Imazeki I; Moriguchi Y; Imai N; Sasaki S; Takeda K; Fukagawa M
    Nephrol Dial Transplant; 2006 Mar; 21(3):651-9. PubMed ID: 16311258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal insufficiency-induced bone loss is associated with an increase in bone size and preservation of strength in rat proximal femur.
    Jokihaara J; Järvinen TL; Jolma P; Kööbi P; Kalliovalkama J; Tuukkanen J; Saha H; Sievänen H; Kannus P; Pörsti I
    Bone; 2006 Aug; 39(2):353-60. PubMed ID: 16584934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia.
    Quarles LD; Lobaugh B; Murphy G
    J Clin Endocrinol Metab; 1992 Jul; 75(1):145-50. PubMed ID: 1619003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
    Joffe P; Heaf JG; Jensen C
    Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bone histology spectrum in experimental renal failure: adverse effects of phosphate and parathyroid hormone disturbances.
    Batista DG; Neves KR; Graciolli FG; dos Reis LM; Graciolli RG; Dominguez WV; Neves CL; Magalhães AO; Custódio MR; Moysés RM; Jorgetti V
    Calcif Tissue Int; 2010 Jul; 87(1):60-7. PubMed ID: 20428857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH) -sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action.
    Klem KH; Jablonski G; Saether O; Jarosz G; Gautvik KM; Gordeladze JO
    Biochim Biophys Acta; 1990 Sep; 1054(3):304-10. PubMed ID: 2169895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
    Cantor T; Sci B
    Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The PTH/PTHrP receptor: biological implications].
    Ureña P
    Nefrologia; 2003; 23 Suppl 2():12-7. PubMed ID: 12778847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis.
    Hirata M; Katsumata K; Masaki T; Koike N; Endo K; Tsunemi K; Ohkawa H; Kurokawa K; Fukagawa M
    Kidney Int; 1999 Dec; 56(6):2040-7. PubMed ID: 10594779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adynamic bone disease: from bone to vessels in chronic kidney disease.
    Bover J; Ureña P; Brandenburg V; Goldsmith D; Ruiz C; DaSilva I; Bosch RJ
    Semin Nephrol; 2014 Nov; 34(6):626-40. PubMed ID: 25498381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new approach for evaluating bone turnover in chronic kidney disease.
    Tolouian R; Hernandez GT; Chiang WY; Gupta A
    Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.
    Li X; Yu L; Asuncion F; Grisanti M; Alexander S; Hensley K; Han CY; Niu QT; Dwyer D; Villasenor K; Stolina M; Dean C; Ominsky MS; Ke HZ; Tomlinson JE; Richards WG
    Bone; 2017 Dec; 105():163-172. PubMed ID: 28867373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
    Monier-Faugere MC; Geng Z; Friedler RM; Qi Q; Kubodera N; Slatopolsky E; Malluche HH
    Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
    Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal resistance to parathyroid hormone as a background abnormality in uremia.
    Fukagawa M; Iwasaki Y; Kazama JJ
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S50-2. PubMed ID: 15012692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
    Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J
    Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parathyroid hormone metabolism and its potential as a uremic toxin.
    Slatopolsky E; Martin K; Hruska K
    Am J Physiol; 1980 Jul; 239(1):F1-12. PubMed ID: 6994509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.